Long-standing issues result in warning letter for Teva
Repeat observations for Teva’s facility results in US FDA issue warning letter, citing ‘inadequate oversight and control by executive management’.
Archives for March 12, 2019
US budget tackles drug costs and generic competition
The US Government released its fiscal year 2020 budget plan, which addressed affordable prescription drug costs through increased generic competition.
NEWS IN BRIEF
Sagent acquires US facility with an eye on future biosimilar products
Sagent purchases Xellia’s FDA-approved site in North Carolina, which has capabilities to manufacture both small molecule and biologic products.
Preclinical CROs partner to provide GLP ototoxicity testing services
Sinclair Research and Turner Scientific sign an exclusive partnership through which the preclinical CROs will offer GLP ototoxicity testing services.
First Poland-based hospital joins Clinerion network
Clinerion gains first Poland-based partner as Szpital Specjalistyczny w Brzozowie joins the global hospital network to bolster data integration.
CRF Bracket sees record new business, eyes future partnerships to build on growth
CRF Bracket closes its first full quarter as a combined entity with more than a 20% increase in new clinical trial business – and will “aggressively look for partners” from its current and future customers, says CEO.
Drug development research agreement leverages simulation platform
Drug development advisory firm Rosa & Co. enters research agreement with Chugai pharmaceutical to provide access to PhysioPD research services for translational biology.